Quinoxaline derivatives: a patent review (2006 – present)
- 13 September 2012
- journal article
- review article
- Published by Informa Healthcare in Expert Opinion on Therapeutic Patents
- Vol. 22 (11) , 1289-1302
Abstract
Introduction: Quinoxaline scaffold is included in a large number of therapeutic agents because of its physicochemical properties that make the difference between them and the carbono analogue, naphthalene. Areas covered: This review of patented products presents the quinoxaline heterocycle as part of the structural patent claims from a medicinal chemistry perspective. Expert opinion: We centred our discussion in the various drug patent applications of the quinoxaline and its derivatives. The applications are based firstly in the specific enzyme target with very low development in the disease treatment. Only for cancer and antimicrobial agents they were specifically determined but little is mentioned in order to insight in the last development activities.Keywords
This publication has 26 references indexed in Scilit:
- Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developmentsBritish Journal of Pharmacology, 2012
- Phosphodiesterase function and endocrine cells: links to human disease and roles in tumor development and treatmentCurrent Opinion in Pharmacology, 2011
- Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancerBreast Cancer Research, 2011
- The aromaticity of substituted diazanaphthalenesComputational and Theoretical Chemistry, 2011
- PDE7 inhibitors as new drugs for neurological and inflammatory disordersExpert Opinion on Therapeutic Patents, 2008
- Chemistry, Biological Properties and SAR Analysis of QuinoxalinonesMini-Reviews in Medicinal Chemistry, 2006
- Quinoxaline 1,4-Dioxide: A Versatile Scaffold Endowed With Manifold ActivitiesCurrent Medicinal Chemistry, 2005
- Heteroaromaticity, 5, a unified aromaticity indexTetrahedron, 1992
- A dipole-moment study of substituted pyrazines and quinoxalinesJournal of Molecular Structure, 1980
- Strained heterocyclic systems. VI. Basicities of some quinoxalinesThe Journal of Organic Chemistry, 1972